UK prices of medicines hit all-time low and are less than in comparable EU countries; RPSGB backs original-pack dispensing

16 December 2009

The UK has dropped to bottom of the official league table comparing the price of medicines across Europe, a Government report has revealed. For the first time, the UK lags behind Austria, Belgium, Finland, France, Germany, Ireland, Italy, Netherlands, Spain and Sweden.

The figures are published in an annual report to Parliament from the Department of Health, which sets the price paid for medicines by the National Health Service. The report compares the 2008 prices of the leading 150 branded medicines in 11 European countries, the USA and Australia. The UK ranks 12 out of 13, behind the USA and all of its counterparts in Europe, with only Australia, a new addition to the list in 2007, coming out lower.

Since 2008, prices have dropped further relative to Europe as there was a cut in January 2009 and sterling has fallen against the euro, and a recent analysis by the Association of the British Pharmaceutical Industry (ABPI) puts the UK behind even Australia in the second quarter of 2009.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical